Preferred Label : Simendan;

MeSH definition : A hydrazone and pyridazine derivative; the levo-form is a phosphodiesterase III inhibitor, calcium-sensitizing agent, and inotropic agent that is used in the treatment of HEART FAILURE.;

MeSH synonym : ((4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl)hydrazono)propanedinitrile;

MeSH hyponym : OR-1259; OR 1855;

MeSH CAS label : Propanedinitrile, 2-(2-(4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl)hydrazinylidene)-;

MeSH Related Number : 131741-08-7 (Simendan); C6T4514L4E;

UNII : 349552KRHK;

Details


Main resources

You can consult :

A hydrazone and pyridazine derivative; the levo-form is a phosphodiesterase III inhibitor, calcium-sensitizing agent, and inotropic agent that is used in the treatment of HEART FAILURE.

https://pharmactuel.com/index.php/pharmactuel/article/view/1294
2019
false
false
false
Canada
drug incompatibility
infusions, intravenous
journal article
ketamine
intensive care
Levosimendan
critical care
dexmedetomidine
Simendan

---
http://www.has-sante.fr/portail/jcms/c_2629887/fr/zimino
2016
false
false
false
France
French
evaluation of the transparency committee
infusions, intravenous
treatment outcome
Levosimendan
Levosimendan
levosimendan
Product containing precisely levosimendan 2.5 milligram/1 milliliter conventional release solution for injection (clinical drug)
heart decompensation
acute disease
adult
cardiotonic agents
cardiotonic agents
emergency treatment
risk management
heart failure
hydrazones
pyridazines
hydrazones
pyridazines
Simendan
Simendan

---
http://revmed.ch/RMS/2005/RMS-21/30464
2005
Switzerland
French
hydrazones
pyridazines
cardiotonic agents
pyridazines
cardiotonic agents
hydrazones
treatment outcome
heart failure, systolic
heart failure, systolic
infusions, intravenous
levosimendan
Levosimendan
Levosimendan
drug information
journal article
Simendan
Simendan
Simendan

---
Nous contacter.
03/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.